Opiate Withdrawal Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Opiate Withdrawal Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05995535

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

A placebo-controlled trial in which male and female outpatients with an opioid use disorder who express interest in extended-release injectable naltrexone (XR-N…

United States150 participantsStarted 2024-01-01

Treatment: LFX/PGB, LFX/PLA-PGB

All recent trials (31 shown)

CompletedNot Applicable

NCT03911739

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

This is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs; Unique protocol ID: 2019-0429-1). Careta…

United States71 participantsStarted 2021-06-14

Treatment: Buprenorphine Injection, Buprenorphine Sublingual Product

CompletedPhase 3

NCT05980260

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approa…

This clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often…

United States626 participantsStarted 2024-03-25

Treatment: Symptom-based Dosing Approach, Scheduled Opioid Taper Approach

Opiate Withdrawal Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

All recent trials (31 shown)

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approa…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

All recent trials (31 shown)

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approa…

Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach

A Study of Oral Ibogaine in Opioid Withdrawal

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

Neurostimulation for Opiate Withdrawal in the PICU

An App to Aid in Transitioning Off Opioid Medication

Buspirone for Opioid Tapering

Pregabalin for Opiate Withdrawal Syndrome

How to Treat Opiate Withdrawal in Neonates

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

Donor Human Milk in Neonatal Abstinence Syndrome

Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal

Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients

Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal